Effectiveness of CTC-96 Against Adenovirus Infections
Author Information
Author(s): Seth P Epstein, Yevgenia Y Pashinsky, David Gershon, Irene Winicov, Charlie Srivilasa, Katarina J Kristic, Penny A Asbell
Primary Institution: Mount Sinai School of Medicine
Hypothesis
CTC-96 may have antiviral activity against adenovirus infections.
Conclusion
CTC-96 demonstrated virucidal activity against adenovirus type 5 in both cell culture and rabbit models.
Supporting Evidence
- CTC-96 was effective against adenovirus type 5 in tissue culture.
- All eyes in the rabbit model developed acute conjunctivitis.
- CTC-96 at 50 ug/ml showed significant improvement in clinical scores.
- Viral clearance was achieved faster in treated groups compared to controls.
- Statistical significance was observed in multiple treatment comparisons.
Takeaway
CTC-96 is a medicine that helps fight a virus that causes eye infections, and it worked well in tests with rabbits.
Methodology
The study involved in vitro assays on human and rabbit cell lines and in vivo testing on New Zealand White rabbits infected with adenovirus.
Limitations
The study's sample size was small, and results may not fully represent human responses.
Participant Demographics
New Zealand White rabbits were used in the study.
Statistical Information
P-Value
p ≤ 0.03 for 50/9 and p ≤ 0.04 for 50/6
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website